The immunomodulatory drug lenalidomide restores a vitamin D sensitive phenotype to the vitamin D resistant breast cancer cell line MDA-MB-231 through inhibition of BCL-2: potential for breast cancer therapeutics

Author: Brosseau Carole   Colston Kay   Dalgleish Angus   Galustian Christine  

Publisher: Springer Publishing Company

ISSN: 1360-8185

Source: Apoptosis, Vol.17, Iss.2, 2012-02, pp. : 164-173

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content